Multi-institutional phase II study of docetaxel (D) and gemcitabine (G) as front-line treatment of patients (pts) with advanced non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Amenedo, M
Mel, JR
Casal, J
Rodriguez, MR
Aparicio, LA
Constenla, M
Lopez, R
Almanza, C
Huarte, L
机构：
[1] Ctr Oncol Galicia, La Coruna, Spain
[2] Hosp Xeral Calde, Lugo, Spain
[3] Hosp Meixoeiro, Vigo, Spain
[4] Hosp Santa Maria Madre, Orense, Spain
[5] Hosp Juan Canalejo, La Coruna, Spain
[6] Complejo Hosp Pontevedra, Pontevedra, Spain
[7] CHUS, Santiago De Compostela, Spain
[8] POVISA, Vigo, Spain
[9] Aventis Pharma, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
511P
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [21] Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer
    Fidias, Panos M.
    Dakhil, Shaker R.
    Lyss, Alan P.
    Loesch, David M.
    Waterhouse, David M.
    Bromund, Jane L.
    Chen, Ruqin
    Hristova-Kazmierski, Maria
    Treat, Joseph
    Obasaju, Coleman K.
    Marciniak, Martin
    Gill, John
    Schiller, Joan H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 591 - 598
  • [22] Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer
    Ma, CX
    Nair, S
    Thomas, S
    Mandrekar, SJ
    Nikcevich, DA
    Rowland, KM
    Fitch, TR
    Windschitl, HE
    Hillman, SL
    Schild, SE
    Jett, JR
    Obasaju, C
    Adjei, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5929 - 5937
  • [23] First-line chemotherapy with planned sequential administration of gemcitabine (G) followed by docetaxel (D) in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study
    Vasile, E.
    Tibaldi, C.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Lo Dico, M.
    Mazzoni, E.
    Andreuccetti, M.
    Falcone, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Weekly administration of docetaxel (D) and gemcitabine (G) as front-line chemotherapy of patients with non-small cell lung cancer: An ongoing phase I study.
    Kouroussis, C
    Kakolyris, S
    Mavroudis, D
    Kalbakis, K
    Stathopoulos, G
    Souglakos, J
    Vamvakas, L
    Xenidis, N
    Samonis, G
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2000, 11 : 114 - 114
  • [25] Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer
    Spigel, David R.
    Greco, F. Anthony
    Thompson, Dana S.
    Webb, Charles
    Rubinsak, James
    Inhorn, Roger C.
    Reeves, James, Jr.
    Vazquez, Elizabeth R.
    Lane, Cassie M.
    Burris, Howard A., III
    Hainsworth, John D.
    CLINICAL LUNG CANCER, 2010, 11 (03) : 198 - 203
  • [26] First line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study
    Lo Dico, M.
    Vasile, E.
    Tibaldi, C.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    D'Alessandro, M.
    Nacci, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 35 - 35
  • [27] A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non-Small-Cell Lung Cancer
    Pallis, Athanasios G.
    Voutsina, Alexandra
    Kentepozidis, Nikolaos
    Giassas, Stylianos
    Papakotoulas, Pavlos
    Agelaki, Sofia
    Tryfonidis, Kostas
    Kotsakis, Athanasios
    Vamvakas, Lambros
    Vardakis, Nikolaos
    Georgoulias, Vassilis
    CLINICAL LUNG CANCER, 2012, 13 (02) : 129 - 135
  • [28] Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic non-small-cell lung cancer: A multicenter phase II study
    Costa, A
    Almodovar, T
    Seada, J
    Barata, F
    Teixeira, E
    Queiroga, H
    Pires, S
    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 117 - 120
  • [29] Phase ii trial with Docetaxel in patients (PTS) with non small cell lung cancer (NSCLC)
    Latreille, J
    Laberge, F
    Viallet, J
    Maksymiuk, A
    Shepherd, F
    Gelman, K
    Delorme, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1070 - 1070
  • [30] Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial
    West, H. L.
    Wakelee, H. A.
    Perry, M. C.
    Belt, R. J.
    Chen, R.
    Obasaju, C.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 850 - 856
12345